SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Martek Biosciences---- future biotech cash cow!

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: richardred who wrote (242)1/5/2006 1:47:47 PM
From: richardred   of 258
 
Takeda sells stake in vitamin bulk firm to BASF Japan
(Kyodo) _ Takeda Pharmaceutical Co. said Thursday it transferred to BASF Japan Ltd. the previous day all of its 34 percent interest in BASF Takeda Vitamin K.K., a joint venture selling bulk vitamins.

The transfer was conducted for an undisclosed sum of money in accordance with the original agreement between Takeda and the subsidiary of the German chemicals maker. The agreement stipulated that the operations of BASF Takeda be handed over to BASF Japan five years after its founding in January 2001.

BASF Takeda is a major supplier of bulk vitamins and other pharmaceutical ingredients.
asia.news.yahoo.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext